About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Biotechnology Innovation Organization (BIO) Elects Mike Huckman to Board of Directors

 Communication expert is a first for BIO board

Real Chemistry, a leading global health innovation company committed to making the world a healthier place for all, today announced that Mike Huckman has been appointed to the Biotechnology Innovation Organization (BIO) Board of Directors, effective immediately.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220613005871/en/

Mike Huckman (Photo: Business Wire)

Mike Huckman (Photo: Business Wire)

Huckman’s appointment was confirmed during the 2022 BIO International Convention taking place this week in San Diego. BIO is the world's largest trade association, representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other countries.

"The importance of communications to science, technology and health care has never been greater. Under the direction of BIO CEO Dr. Michelle McMurray-Heath, the organization has built one of the most far-reaching and forward-thinking communications operations in public advocacy,” says John F. Crowley, CEO of Amicus Therapeutics and chair of the Emerging Companies Section of the BIO Board of Directors. “Mike’s decades of experience and leadership in biotech journalism and corporate communications strategy will be a perfect complement to the great work already being done at BIO and will provide the board with an important perspective.”

One of BIO’s key pillars is positioning itself as the “voice of science and for science.” Communications is integral to uniting and empowering biotech innovators to improve lives through advocacy that fights for science, removes barriers to innovation, champions broad access to biotech breakthroughs, and improves equitable access.

“We are thrilled for this new opportunity for Mike, this recognition of the caliber of his leadership, and the importance of communications to the biotechnology industry,” said Shankar Narayanan, CEO of Real Chemistry. “Our team continues to pioneer new ways to apply AI and ideas to transform health care. Together, with our partners and clients, we can build a new approach to bringing life-saving medicines to all who need them.”

Huckman serves as the global practice leader for executive communications at Real Chemistry where he works directly with C-suite clients at major pharmaceutical and biotechnology companies, ranging from large-cap organizations to start-ups. Prior to his time at Real Chemistry, Huckman was a decorated journalist who won several awards including three Emmys. He worked at CNBC for a decade as the first-ever correspondent at the global business news network, specializing in coverage of the pharmaceutical, biotech and medical device sectors.

“I am extremely honored to be asked to join BIO’s Board of Directors,” said Huckman. “After covering the life sciences as a reporter and working with biotech leaders as a consultant for decades, I know we are on the cusp of a new, revolutionary era in biotechnology. I look forward to working with the board to help share and celebrate the magic behind the medicines and the mind-blowing ingenuity of emerging science and technology that is changing peoples’ lives and the world.”

About Real Chemistry

Real Chemistry is making the world a healthier place by empowering patients to access the right treatment at the right time. We leverage the best data-driven, tech-enabled and digital solutions to deliver communications, engagement, activation and value across a full range of diverse health care stakeholders — patients, payors, providers, caregivers and regulators.

Our patient-centric approach pairs owned and partnered real-world data sources and proprietary technologies with analytical insights and modern marketing and communications services to solve today’s biggest engagement and commercialization challenges, including diversifying and speeding clinical trial awareness and enrollment, expanding product lifecycles, and shortening the revenue curve. From finding patients with complicated or rare diseases to participate in clinical trials to targeting omnichannel marketing efforts to exactly the right audience, Real Chemistry is advancing transformation at the intersection of consumerization, personalization and digitization impacting health care today.

For more information, please visit www.realchemistry.com and connect with us on Twitter and LinkedIn.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.